| # | Drug | Count |
|---|---|---|
| 0 | PROGESTERONE | 11 |
| 1 | QUETIAPINE | 10 |
| 2 | RALTEGRAVIR | 9 |
| 3 | VENLAFAXINE | 9 |
| 4 | VENLAFAXINE HYDROCHLORIDE | 9 |
| 5 | CITALOPRAM | 7 |
| 6 | CITALOPRAM HYDROBROMIDE | 7 |
| 7 | DARUNAVIR | 7 |
| 8 | ESCITALOPRAM | 7 |
| 9 | FOLIC ACID | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MARAVIROC | 7 | 0.0031 |
| 1 | ACONITUM NAPELLUS, ARSENIC TRIOXIDE, ATROPA BELLADONNA, BRYONIA ALBA ROOT, EUPATORIUM PERFOLIATUM FLOWERING TOP, FERRUM PHOSPHORICUM, GELSEMIUM SEMPERVIRENS ROOT | 1 | 0.0024 |
| 2 | RALTEGRAVIR | 9 | 0.0017 |
| 3 | METHYLDOPA | 7 | 0.0014 |
| 4 | HUMAN RHO(D) IMMUNE GLOBULIN | 1 | 0.0010 |
| 5 | NELFINAVIR MESYLATE | 1 | 0.0005 |
| 6 | PROGESTERONE | 11 | 0.0005 |
| 7 | DARUNAVIR | 7 | 0.0005 |
| 8 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 9 | MISOPROSTOL | 2 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progesterone [EPC] | 11 |
| 1 | CCR5 Co-receptor Antagonist [EPC] | 7 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 7 |
| 3 | Protease Inhibitor [EPC] | 7 |
| 4 | Serotonin Reuptake Inhibitor [EPC] | 7 |
| 5 | Vitamin B12 [EPC] | 7 |
| 6 | Vitamin C [EPC] | 7 |
| 7 | Vitamin D [EPC] | 7 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 7 | 0.0031 |
| 1 | Progesterone [EPC] | 11 | 0.0005 |
| 2 | Protease Inhibitor [EPC] | 7 | 0.0002 |
| 3 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 7 | 0.0001 |
| 5 | Serotonin Reuptake Inhibitor [EPC] | 7 | 0.0001 |
| 6 | Cholinergic Nicotinic Agonist [EPC] | 3 | 0.0000 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |